Novo Nordisk A/S (NVO) — the peer cohort
As of 2026-11-10 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
Novo Nordisk A/S ranks 16 of 16 in its cohort on the Closelooknet composite (55/100) — the cohort is led by Ferrari NV at 66/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| NVO Novo Nordisk A/S | 55 | 28 | 86 | 72 | neutral | 33.1% |
| RACE Ferrari NV | 66 | 79 | 83 | 23 | watch | 15.5% |
| LLY Eli Lilly and Company | 64 | 91 | 90 | 22 | bull | 2.8% |
| REGN Regeneron Pharmaceuticals Inc | 64 | 84 | 72 | 45 | bull | 7.2% |
| DXCM DexCom Inc | 62 | 67 | 79 | 34 | watch | 12.4% |
| HDB HDFC Bank Limited ADR | 62 | 52 | 66 | 80 | bull | 28.9% |
| TOST Toast Inc | 62 | 76 | 51 | 41 | watch | 12.5% |
| GMED Globus Medical | 60 | 37 | 65 | 53 | bull | 24.7% |
| ONON On Holding Ltd | 60 | 45 | 69 | 45 | watch | 26.5% |
| VRSK Verisk Analytics Inc | 60 | 69 | 88 | 33 | neutral | 19.2% |
| FAST Fastenal Company | 59 | 83 | 71 | 19 | bull | 0.8% |
| IDXX IDEXX Laboratories Inc | 59 | 71 | 85 | 17 | bull | 8.2% |
| ZEAL.CO Zealand Pharma A/S | 59 | 11 | 71 | 77 | bull | 55.9% |
| ORNAV.HE Orion Oyj A | 63 | 94 | 84 | 29 | ok | 1.4% |
| ORNBV.HE Orion Oyj B | 63 | 94 | 84 | 29 | ok | 1.4% |
| SAN.PA Sanofi SA | 63 | 75 | 69 | 63 | bull | 0.7% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-10
Quick answers
Who are Novo Nordisk A/S's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Ferrari NV (RACE), Eli Lilly and Company (LLY), Regeneron Pharmaceuticals Inc (REGN), DexCom Inc (DXCM), HDFC Bank Limited ADR (HDB), Toast Inc (TOST), Globus Medical (GMED), On Holding Ltd (ONON) and others, as of 2026-11-10.
How does NVO score against its peers?
Novo Nordisk A/S's composite reads 55/100, ranking 16 of 16 in its cohort as of 2026-11-10; the cohort's highest composite is Ferrari NV at 66/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where NVO appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- Midterms — Dow Jumps 2.3% and Apple Hits a Record; Data-Center Power Stocks Sink Up to 15%
Novo Nordisk — outlook raised, shares up 6%
Related in the Closelooknet universe
same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- RACE Ferrari NV
- LLY Eli Lilly and Company
- REGN Regeneron Pharmaceuticals Inc
- DXCM DexCom Inc
- HDB HDFC Bank Limited ADR
- TOST Toast Inc
- GMED Globus Medical
- ONON On Holding Ltd
- VRSK Verisk Analytics Inc
- FAST Fastenal Company
- IDXX IDEXX Laboratories Inc
- ZEAL.CO Zealand Pharma A/S
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- AZN.L AstraZeneca PLCindustry
- GSK GSK plcindustry
- AMGN Amgen Incindustry
- SNY Sanofi ADRindustry
- GILD Gilead Sciences Incindustry